Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis By Cancer Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate By Cancer Type: 2018 VS 2022 VS 2033
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Leukemia
1.2.6 Prostate Cancer
1.2.7 Cervical Cancer
1.2.8 Glioblastoma
1.2.9 Others
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2018-2033)
2.2 Personalized Cancer Vaccines Growth Trends by Region
2.2.1 Global Personalized Cancer Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Personalized Cancer Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Region (2024-2033)
2.3 Personalized Cancer Vaccines Market Dynamics
2.3.1 Personalized Cancer Vaccines Industry Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2018-2023)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2022
3.5 Personalized Cancer Vaccines Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
3.7 Date of Enter into Personalized Cancer Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2024-2033)
5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2018-2033)
6.2 North America Personalized Cancer Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Personalized Cancer Vaccines Market Size by Country (2018-2023)
6.4 North America Personalized Cancer Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2018-2033)
7.2 Europe Personalized Cancer Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Personalized Cancer Vaccines Market Size by Country (2018-2023)
7.4 Europe Personalized Cancer Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2018-2033)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2018-2033)
9.2 Latin America Personalized Cancer Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Personalized Cancer Vaccines Market Size by Country (2018-2023)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2018-2033)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Detail
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Detail
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Detail
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Detail
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Detail
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Detail
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Detail
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Detail
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Detail
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Detail
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Detail
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2018-2023)
11.12.5 Moderna Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Lung Cancer
Table 3. Key Players of Breast Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Leukemia
Table 6. Key Players of Prostate Cancer
Table 7. Key Players of Cervical Cancer
Table 8. Key Players of Glioblastoma
Table 9. Key Players of Others
Table 10. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Personalized Cancer Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Personalized Cancer Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Personalized Cancer Vaccines Market Share by Region (2018-2023)
Table 14. Global Personalized Cancer Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Personalized Cancer Vaccines Market Share by Region (2024-2033)
Table 16. Personalized Cancer Vaccines Market Trends
Table 17. Personalized Cancer Vaccines Market Drivers
Table 18. Personalized Cancer Vaccines Market Challenges
Table 19. Personalized Cancer Vaccines Market Restraints
Table 20. Global Personalized Cancer Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Personalized Cancer Vaccines Market Share by Players (2018-2023)
Table 22. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2022)
Table 23. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Personalized Cancer Vaccines Product Solution and Service
Table 27. Date of Enter into Personalized Cancer Vaccines Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Personalized Cancer Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Type (2018-2023)
Table 31. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Personalized Cancer Vaccines Revenue Market Share by Type (2024-2033)
Table 33. Global Personalized Cancer Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Personalized Cancer Vaccines Revenue Market Share by Application (2018-2023)
Table 35. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Personalized Cancer Vaccines Revenue Market Share by Application (2024-2033)
Table 37. North America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Personalized Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Personalized Cancer Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Personalized Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Personalized Cancer Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Personalized Cancer Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Personalized Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Personalized Cancer Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Personalized Cancer Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 52. Advaxis Inc Company Detail
Table 53. Advaxis Inc Business Overview
Table 54. Advaxis Inc Personalized Cancer Vaccines Product
Table 55. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 56. Advaxis Inc Recent Development
Table 57. Personalis Company Detail
Table 58. Personalis Business Overview
Table 59. Personalis Personalized Cancer Vaccines Product
Table 60. Personalis Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 61. Personalis Recent Development
Table 62. Hoffmann-La Roche Ltd Company Detail
Table 63. Hoffmann-La Roche Ltd Business Overview
Table 64. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product
Table 65. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 66. Hoffmann-La Roche Ltd Recent Development
Table 67. BioNtech Company Detail
Table 68. BioNtech Business Overview
Table 69. BioNtech Personalized Cancer Vaccines Product
Table 70. BioNtech Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 71. BioNtech Recent Development
Table 72. Celldex Company Detail
Table 73. Celldex Business Overview
Table 74. Celldex Personalized Cancer Vaccines Product
Table 75. Celldex Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 76. Celldex Recent Development
Table 77. CureVac AG Company Detail
Table 78. CureVac AG Business Overview
Table 79. CureVac AG Personalized Cancer Vaccines Product
Table 80. CureVac AG Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 81. CureVac AG Recent Development
Table 82. Genetech Company Detail
Table 83. Genetech Business Overview
Table 84. Genetech Personalized Cancer Vaccines Product
Table 85. Genetech Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 86. Genetech Recent Development
Table 87. Genocea Company Detail
Table 88. Genocea Business Overview
Table 89. Genocea Personalized Cancer Vaccines Product
Table 90. Genocea Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 91. Genocea Recent Development
Table 92. Gritstone Oncology Company Detail
Table 93. Gritstone Oncology Business Overview
Table 94. Gritstone Oncology Personalized Cancer Vaccines Product
Table 95. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 96. Gritstone Oncology Recent Development
Table 97. ISA Pharmaceuticals Company Detail
Table 98. ISA Pharmaceuticals Business Overview
Table 99. ISA Pharmaceuticals Personalized Cancer Vaccines Product
Table 100. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 101. ISA Pharmaceuticals Recent Development
Table 102. Merck Company Detail
Table 103. Merck Business Overview
Table 104. Merck Personalized Cancer Vaccines Product
Table 105. Merck Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Moderna Therapeutics Company Detail
Table 108. Moderna Therapeutics Business Overview
Table 109. Moderna Therapeutics Personalized Cancer Vaccines Product
Table 110. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2018-2023) & (US$ Million)
Table 111. Moderna Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Cancer Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Personalized Cancer Vaccines Market Share by Type: 2022 VS 2033
Figure 3. Lung Cancer Features
Figure 4. Breast Cancer Features
Figure 5. Colorectal Cancer Features
Figure 6. Leukemia Features
Figure 7. Prostate Cancer Features
Figure 8. Cervical Cancer Features
Figure 9. Glioblastoma Features
Figure 10. Others Features
Figure 11. Global Personalized Cancer Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Personalized Cancer Vaccines Market Share by Application: 2022 VS 2033
Figure 13. Hospitals Case Studies
Figure 14. Homecare Case Studies
Figure 15. Specialty Clinics Case Studies
Figure 16. Others Case Studies
Figure 17. Personalized Cancer Vaccines Report Years Considered
Figure 18. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global Personalized Cancer Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Personalized Cancer Vaccines Market Share by Region: 2022 VS 2033
Figure 21. Global Personalized Cancer Vaccines Market Share by Players in 2022
Figure 22. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Vaccines as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2022
Figure 24. North America Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America Personalized Cancer Vaccines Market Share by Country (2018-2033)
Figure 26. United States Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Europe Personalized Cancer Vaccines Market Share by Country (2018-2033)
Figure 30. Germany Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2018-2033)
Figure 38. China Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Japan Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. India Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Australia Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Latin America Personalized Cancer Vaccines Market Share by Country (2018-2033)
Figure 46. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2018-2033)
Figure 50. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 53. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 54. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 55. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 56. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 57. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 58. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 59. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 60. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 61. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 63. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed